UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000033961 |
|---|---|
| Receipt number | R000038737 |
| Scientific Title | Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial) |
| Date of disclosure of the study information | 2018/08/30 |
| Last modified on | 2024/03/26 18:25:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/08/30 19:31:50 | ||
| 2 | Update | 2018/08/30 19:36:54 | Key secondary outcomes |
|
| 3 | Update | 2018/09/04 09:47:32 | Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2018/09/04 10:52:15 | Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2019/03/04 18:17:30 | Recruitment status |
|
| 6 | Update | 2022/03/02 10:11:20 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization1 Email1 Organization Organization Address Address Tel |
|
| 7 | Update | 2022/03/02 10:47:10 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 8 | Update | 2022/09/02 15:26:09 | Recruitment status |
|
| 9 | Update | 2024/03/26 18:25:43 | Recruitment status |
